Celularity (CELU) announced that the Nasdaq Listing Qualifications Hearings Panel has cancelled the hearing regarding Celularity’s non-compliance with Nasdaq Listing Rules as the company has cured its filing delinquency. The matter is now closed, and Nasdaq has confirmed that Celularity’s stock will continue to be listed and traded on The Nasdaq Stock Market. Celularity filed its Form 10-Q for the period ended March 31 on October 16, and its Form 10-Q for the period ended June 30, on November 7, achieving compliance with Nasdaq requirements.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CELU:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue